{"id":"W2011837830","doi":"10.1053/j.gastro.2014.05.008","title":"Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed","year":2014,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":705,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Robarts Clinical Trials; Western University","funders":"Janssen Pharmaceuticals; Takeda Pharmaceuticals International; Takeda Oncology","keywords":"Vedolizumab; Medicine; Crohn's disease; Tumor necrosis factor alpha; Antagonist; Internal medicine; Disease; Induction therapy; Gastroenterology; Chemotherapy; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001615221,0.0003214169,0.0009982061,0.0001816237,0.0002079598,0.0004195389,0.0002877635,0.0005038336,0.001585719],"category_scores_gemma":[0.002704872,0.0001616771,0.0008031069,0.0001705467,0.0003450454,0.0003849289,0.0002344924,0.001311352,0.0001700533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002919932,"about_ca_system_score_gemma":0.0003702687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002716957,"about_ca_topic_score_gemma":0.0007219005,"domain_scores_codex":[0.9994081,0.0003452458,0.00005826993,0.00006402723,0.00005528336,0.00006909439],"domain_scores_gemma":[0.9979985,0.0009677227,0.0005430042,0.00007510898,0.00005721165,0.0003584278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6286404,0.01217341,0.05738368,0.001094723,0.001408669,0.0004210639,0.0003170001,0.0009543509,0.02084778,0.0001555164,0.001523091,0.2750804],"study_design_scores_gemma":[0.1889187,0.5107674,0.2855258,0.0003102092,0.002104699,0.0009628836,0.0001668413,0.002201742,0.0057366,0.0002458578,0.003015008,0.00004431259],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942452,0.004578793,0.0001232416,0.0001984554,0.00004660173,0.0001055065,0.00006715943,0.00001286985,0.0006222096],"genre_scores_gemma":[0.9978393,0.001277318,0.0002486526,0.0002228737,0.00006488903,0.00007866563,0.0001037235,0.00000230896,0.0001621529],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001615221,"threshold_uncertainty_score":0.00854224,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003907753080859614,"score_gpt":0.2068866383812248,"score_spread":0.2029788853003652,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}